NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
Back to search
Official data from USPTO
SK LIFE SCIENCE LABS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/04/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
10/27/2023
Registration date
11/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
11/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Seoul, KR
Examiner
COGAN, BRITTNEY LORRAINE
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "SK" in red stylized font and the letters "life science labs" in orange stylized font. To the top right of the "SK" portion of the mark is a design of wings. The inner portion of the wings is red, and the outer portion of the wings is orange. White is not claimed as a feature of the mark and only represents background or transparent areas.
Holders and representatives
Holders
SK Inc.
Representatives
Hun Joon Kim LEX IP Meister, PLLC.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes for the treatment and prevention of central nervous system diseasescancermetabolic diseasesallergyimmunological diseases and disordersneurological diseases and disorderscardiac diseases and disordersdermatological diseases and disordersendocrinological diseases and disordersgastroenterological diseases and disordershematological diseases and disordersinfectious diseases and disordersgenetic diseases and disordersnephrological diseases and disordersgynecological diseases and disordersophthalmological diseases and disordersorthopedic diseases and disordersotorhinolaryngological diseases and disorderspodiatric diseases and disorderspsychiatric diseases and disorderspulmonological diseases and disordersrespiratory diseases and disordersrheumatological diseases and disordersurological diseases and disordersauto-immune diseases and disorders; chemical preparations for pharmaceutical purposesfor the treatment and prevention of central nervous system diseasescancermetabolic diseasesallergyimmunological diseases and disordersneurological diseases and disorderscardiac diseases and disordersdermatological diseases and disordersendocrinological diseases and disordersgastroenterological diseases and disordershematological diseases and disordersinfectious diseases and disordersgenetic diseases and disordersnephrological diseases and disordersgynecological diseases and disordersophthalmological diseases and disordersorthopedic diseases and disordersotorhinolaryngological diseases and disorderspodiatric diseases and disorderspsychiatric diseases and disorderspulmonological diseases and disordersrespiratory diseases and disordersrheumatological diseases and disordersurological diseases and disordersauto-immune diseases and disorders; sanitary preparations for medical purposes; ferments for pharmaceutical purposes; pharmaceutical preparationsimmunomodulators; vitamin preparations; vaccines; nutritional additives in the nature of dietary supplements for use in foods for human consumption; bacteriological preparations for medical and veterinary use; veterinary preparations for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions
Class 42
Technical project studiesconducting clinical trials for others; development of new technology for others in the field of biotechnology; biotechnology research; biotechnology servicesresearch and development in the biotechnology fields; biotechnology servicesproviding information on the subject of scientific research in the field of biotechnology; biochemical analysis; research and development of new products for others; research relating to pharmaceuticals; product development consultationanalysis and evaluation of medical product development; testinginspection or research of pharmaceuticals; pharmaceutical product evaluation; medical research; chemical research; development and test of chemical production methods
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
ISCR
WITHDRAWN FROM ISSUE - OG REVIEW QUERY
08/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/24/2025
PUBO
PUBLISHED FOR OPPOSITION
06/24/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/18/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/30/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/14/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/03/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/03/2025
CNSI
SUSPENSION INQUIRY WRITTEN
03/03/2025
DOCK
ASSIGNED TO EXAMINER
03/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2024
ALIE
ASSIGNED TO LIE
12/17/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/15/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
11/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/15/2024
DOCK
ASSIGNED TO EXAMINER
09/29/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/01/2024
GNSL
LETTER OF SUSPENSION E-MAILED
06/01/2024
CNSL
SUSPENSION LETTER WRITTEN
06/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2024
GNRT
NON-FINAL ACTION E-MAILED
02/07/2024
CNRT
NON-FINAL ACTION WRITTEN
02/07/2024
DOCK
ASSIGNED TO EXAMINER
01/29/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2023
NWAP
NEW APPLICATION ENTERED
10/31/2023
Continuous trademark protection
Get notified about every new filing that threatens SK LIFE SCIENCE LABS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.